Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sepracor Sees Sweet Dreams For Lunesta Despite Generic Ambien Next Year

This article was originally published in The Pink Sheet Daily

Executive Summary

Firm says formulary placement of the sleep aid will help mitigate Rx erosion following the launch of generic Ambien.

You may also be interested in...



Coupon Redemption On The Rise: A Recession-Proof Boost For Scripts?

Coupon redemptions for prescription drugs more than doubled in 2008 compared to 2007, according to a telephone and internet study of 8,700 consumers conducted by Manhattan Research, a research division of Decision Resources

Coupon Redemption On The Rise: A Recession-Proof Boost For Scripts?

Coupon redemptions for prescription drugs more than doubled in 2008 compared to 2007, according to a telephone and internet study of 8,700 consumers conducted by Manhattan Research, a research division of Decision Resources

Addition Of Lunesta To Lexapro Provides Benefits, Study Finds

The sleep aid combined with Lexapro shows a significant improvement in sleep measures compared to Lexapro and placebo.

Related Content

Topics

UsernamePublicRestriction

Register

OM006051

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel